Fexinidazole: A Potential New Drug Candidate for Chagas Disease

Chronic phase of Chagas disease: why should it be treated? A comprehensive review

(2014) José Rodrigues Coura et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Effects of Ravuconazole Treatment on Parasite Load and Immune Response in Dogs Experimentally Infected with Trypanosoma cruzi

(2010) L. d. F. Diniz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis

(2010) A. Y. Sokolova et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential new drugs for human African trypanosomiasis: some progress at last

(2010) Michael P Barrett   CURRENT OPINION IN INFECTIOUS DISEASES

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

(2010) Margoth Moreno et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Fexinidazole – A New Oral Nitroimidazole Drug Candidate Entering Clinical Development for the Treatment of Sleeping Sickness

(2010) Els Torreele et al.   PLoS Neglected Tropical Diseases

New Advances in the Management of a Long‐Neglected Disease

(2009) Julio A. Urbina   CLINICAL INFECTIOUS DISEASES

Ergosterol biosynthesis and drug development for Chagas disease

(2009) Julio A Urbina   MEMORIAS DO INSTITUTO OSWALDO CRUZ

New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development

(2008) J. van den Boogaard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions

(2008) Ivo Santana Caldas et al.   PARASITOLOGY RESEARCH

Trypanosoma cruzi: Acute and long-term infection in the vertebrate host can modify the response to benznidazole

(2007) Sérgio Caldas et al.   EXPERIMENTAL PARASITOLOGY